mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
0.073 |
0.06 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.06 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.06 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.06 |
mRNA |
UNC0638 |
GDSC1000 |
pan-cancer |
AAC |
-0.058 |
0.06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.06 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.06 |
mRNA |
StemRegenin 1 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.06 |
mRNA |
SN-38 |
GDSC1000 |
pan-cancer |
AAC |
0.064 |
0.06 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.07 |